Company ProfilePremium

The Sustainable Nutrition Group Ltd

Company Profile Analysis

Ticker: EXL.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
The Sustainable Nutrition Group Ltd - Company showcase

Year Founded & Workforce

2017

The Sustainable Nutrition Group Ltd logo

The Sustainable Nutrition Group Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

The Sustainable Nutrition Group Ltd Overview

1A. Current entity — Elixinol Wellness Limited

FieldDetail
Legal nameElixinol Wellness Limited
Former namesElixinol Global Limited (renamed 2022; FY2022 Annual Report notes "formerly known as Elixinol Global Limited")
Founding year2017 (company incorporation; per StockAnalysis company profile)
Incorporation jurisdictionAustralia (public company limited by shares)
ACN / ABNACN 621 479 794 / ABN 34 621 479 794
HeadquartersSuite 2, Level 11, 385 Bourke Street, Melbourne VIC 3000 (FY25 results release, 27 Feb 2026). Earlier address: Level 4, 100 Albert Road, South Melbourne VIC 3205 (Q3 FY24 4C, Oct 2024)
Stock exchange / tickersASX: EXL; US OTC: ELLXF
ISIN / CUSIP—
Fiscal year end31 December
EmployeesNot publicly disclosed in sources reviewed (3-year trend not available)
AuditorFY25 financial statements received an unmodified audit opinion (TipRanks summary of FY25 Appendix 4E)
Share priceA$0.007 (16 October 2026 close, StockAnalysis); A$0.006 intraday 13 October 2026 (Kalkine)
Shares outstanding413.99 million (31 Dec 2025 and 30 Jun 2026; S&P Global via StockAnalysis)
Market capitalisation~A$2.9 million (StockAnalysis, latest); multiples.vc cites ~US$2 million (Oct 2026)
FY25 revenueA$15.5 million (+3.6% YoY)
FY25 net loss after taxA$5.5 million
Cash at 30 Jun 2026A$0.996 million
Websitewww.elixinolwellness.com; investor hub investorhub.elixinolwellness.com
ChairGavin Evans (independent non-executive, appointed December 2025)
CEONatalie Butler (CEO & Executive Director)
CFOAdam Dimitropoulos

1B. Historical entity — The Sustainable Nutrition Group Ltd (as last reported)

FieldDetail
Legal nameThe Sustainable Nutrition Group Limited
Former namesAlchemia Limited (to Oct 2019); Australian Primary Hemp Limited (Oct 2019 – Oct 2021)
ABN43 071 666 334
IncorporationAustralia, 1995 (as Alchemia)
Registered officeLevel 4, 100 Albert Road, South Melbourne VIC 3205
Principal place of business53 Riversdale Road, Newtown VIC 3220 (Geelong)
Former ASX codesACL → APH → TSN
Fiscal year end30 June
AuditorWilliam Buck Audit (Vic) Pty Ltd (H1 FY23 review report)
Company secretaryMelanie Leydin
Share registryLink Market Services
Shares on issue at 31 Dec 2022120,606,385 ordinary shares
Last market cap (aggregator)~A$1.41 million (MarketBeat/iocharts, stale data)
Website (last)www.sustainablenutrition.com.au
Subsidiaries at 31 Dec 2022Alchemia Oncology Pty Ltd; The Sustainable Nutrition Group (Australia) Pty Ltd (formerly Australian Primary Hemp Pty Ltd); The Australian Superfood Co. — each 100% owned

1C. Positioning statement

Elixinol Wellness is a micro-cap Australian health-and-wellness consumer goods group that, through a 2023 merger with The Sustainable Nutrition Group (formerly Australian Primary Hemp), assembled one of Australia's larger domestic hemp-food supply chains alongside a portfolio of branded nutrition products. Its brands span hemp foods (Hemp Foods Australia, Australian Primary Hemp), better-for-you grocery snacks (Mt Elephant), native superfood ingredients (The Australian Superfood Co), premium protein and wellness powders sold mainly online (The Healthy Chef), and bulk hemp ingredients supplied under contract to two major grocery programs. Having exited its US CBD business in September 2026, the company is repositioning as a purely Australian "everyday wellness" platform and has agreed to acquire Vitable, a personalised-supplement subscription business, which would lift annual revenue above A$20 million. The investment case rests on margin expansion (gross margin ~45% in 1H FY26), cost discipline and accretive roll-up M&A, against a fragile balance sheet, heavy dilution and a long record of losses.


2A. Company's own description

In its FY25 results release (27 February 2026), EXL describes itself as a health and wellness company that innovates, markets and sells hemp and other plant-derived food, skincare and nutraceutical products, operating a vertically integrated business that produces, manufactures and distributes products across nutrition, wellness and superfood-ingredient verticals, sold under Hemp Foods Australia, The Healthy Chef, Mt Elephant and The Australian Superfood Co through grocery, wholesale and e-commerce channels. Following the September 2026 US divestment, its boilerplate was updated to describe a sustainable nutrition and wellness company operating in Australia with a vertically integrated healthy-food business (ASX announcement, 7 September 2026).

TSN's last self-description (H1 FY23 interim report, 27 February 2023) characterised it as a vertically integrated producer, manufacturer and distributor of sustainable, plant-based nutrition brands — hemp products under Mt Elephant, Australian Primary Hemp, Australian Superfoods and Field Day — sold to retail, wholesale, e-commerce and white-label customers in Australia, with activities spanning seed selection, farming, processing, packaging, distribution and sales of bulk, food-service and retail products.

2B. Business model and value-chain position

The legacy APH model was "paddock-to-plate": APH purchased hemp cultivation seed, supplied it to a contracted grower network, bought back harvested grain under contract, and processed it (de-hulling, cold pressing, milling) in its own facility before selling bulk ingredients, white-label packs and branded retail products (SmallCaps, Oct 2019; Alchemia prospectus as reported). It did not breed seed itself but sourced genetics through a network that included prominent plant breeders (Stockhead, 2019). This structure created working-capital intensity — TSN carried A$3.28 million of inventory against A$1.86 million of half-year revenue at 31 December 2022, and had outstanding grain-purchase commitments of A$0.58 million (TSN H1 FY23 interim report).

EXL today layers branded consumer businesses on that supply base:

Upstream / ingredients: hemp grain sourcing, de-hulling and processing (APH, Hemp Foods Australia, Ananda Food assets acquired 2024); bulk supply contracts with two major grocery retailers' programs running to 2027 (Food & Drink Business; Grafa, Oct 2026).

Contract manufacturing and white label: supply to grocery private-label and food, beverage and beauty manufacturers (StockAnalysis profile).

Branded retail: Hemp Foods Australia, Mt Elephant (Coles-only from 2026), The Healthy Chef (e-commerce plus a ~410-store Priceline rollout).

Direct-to-consumer: The Healthy Chef e-commerce (A$4.3 million revenue in FY25) and, if approved, Vitable subscriptions.

2C. Revenue model mix

Channel mix (Australia unless noted)FY24FY25
E-commerce revenue (AUD M)1.64.3
Retail channel revenue (AUD M)8.87.1
E-commerce share of group revenue (%)2138
Bulk ingredients share of group revenue (%)2414

Source: EXL FY25 results release (27 Feb 2026) and Q4 FY25 earnings call (CFO commentary, 11–12 Feb 2026). Revenue is overwhelmingly product sales recognised at a point in time; there is no material service, licensing or subscription revenue today. The pending Vitable acquisition would introduce subscription revenue for the first time.

2D. Customer types and end-markets

Customer types: major supermarket chains (Coles; Woolworths until end-2025 for Mt Elephant), pharmacy (Priceline), club retail (Costco — Hemp Gold Protein, returning Q4 2026), convenience (7-Eleven historically), health-food independents, food manufacturers buying bulk ingredients, private-label grocery programs, and online consumers. End-markets: plant-based foods, sports and protein nutrition, functional beverages (protein water), women's health (menopause product), superfood ingredients, pet and equine nutrition (Field Day, Ananda Equine), and — until September 2026 — US CBD nutraceuticals.

Customer concentration was a defining TSN risk: four customers accounted for 60.2% of TSN external revenue in H1 FY22, falling to 34.1% in H1 FY23 after the loss of a key strategic supply agreement (TSN H1 FY23 interim report, Note 3).

2E. Independent characterisation

EXL is best understood as a sub-scale consumer packaged goods roll-up in the Australian better-for-you segment, built on the remnants of two separate hemp ventures (Elixinol's CBD business and APH's hemp food supply chain), neither of which achieved profitability independently. The group's real asset base is (i) a domestic hemp-processing capability and associated grocery supply contracts, and (ii) one genuinely high-margin brand (The Healthy Chef). Everything else is either in managed decline (Mt Elephant at Woolworths, US CBD) or low-margin bulk supply. Strategic value hinges on whether the newly assembled management team can convert gross-margin gains into sustainable positive operating cash flow before the balance sheet forces further deeply dilutive capital raising.

Strategy

10A. Stated strategy themes

Vision: build a portfolio of premium branded health-food assets with Australian manufacturing capability and global growth potential — framed as a "healthy food roll-up" (May 2026 investor presentation; FY25 release).

Positioning: a diversified health and nutrition platform built around longevity and "everyday wellness", executing against wellness megatrends such as food-first and grocery-led wellness (Q4 FY25 and May 2026 presentations). Management cites an Australian wellness market of ~A$160 billion growing to ~A$307 billion by 2033 (~7% CAGR, Global Wellness Institute data as cited by EXL).

Operating priorities for 2026: sustain positive underlying operating cash flow; grow through new retail distribution, product launches and additional B2B contracts; concentrate investment on the strongest brands (The Healthy Chef, Hemp Foods Australia); keep a lean cost base (H1 FY26 commentary).

M&A discipline: actively assess value-accretive acquisitions that use existing infrastructure and distribution or add complementary capabilities.

10B. Strategic initiatives (last 24 months)

InitiativeDateDetailStatus
Healthy Chef integration and innovation2,025Six launches: menopause product, three protein waters, two limited-edition powdersDelivered
SKU and brand rationalisation2025–2026Exit of unprofitable products and duplicate hemp brandsOngoing
Cost reset2,025Q4 FY25 cost base 30% below pcp; 1H FY26 opex down 25%Delivered
Contract renegotiation2,025Legacy contracts renegotiated; expanded hemp supply contracts secured for 2026Delivered
Mt Elephant resetEnd-2025 / 2026Exit Woolworths; Coles-only with co-developed innovationIn progress
Priceline rollout2,026The Healthy Chef in ~410 Priceline storesStage one underway
Costco relaunchQ4 2026Hemp Gold Protein back in Costco AU/NZScheduled
US divestmentAug–Sep 2026Sale of Elixinol LLC to Ananda HealthCompleted
Vitable acquisitionSep 2026Subscription platform, cross-selling Healthy Chef into Vitable basePending shareholder approval
Capital management2025–2026A$1.5 million debt/equity (1H FY25); A$2.5 million raise (2H FY25); loan-note rollover; approval sought for up to A$2 million convertible notes (May 2026 AGM)Ongoing

10C. Medium-term targets

TargetDetailSource
Combined revenue after VitableMore than A$20 million annualised from completionEXL announcement, 24 Sep 2026
2028 target (with full earn-out)~A$27 million revenue and ~A$3 million EBITDABusiness News Australia; SmallCaps
Illustrative ambition~A$50 million revenue over three to five years — explicitly not formal guidanceStartupResearcher
Earlier targetEBITDA break-even in FY25 (stated Feb 2025)Not achieved for the full year; Adjusted EBITDA positive in Q4 FY25 only

Sustainability-specific commitments (emissions targets) were not disclosed.

Products & Services

5A. Australia — Hemp foods and ingredients

Brand / productDescription and capabilitiesTarget customerLaunch / statusPricing
Hemp Foods Australia (flagship brand)EXL's flagship Australian hemp foods brand (Byron Bay origin): hemp seeds, protein and oil range; revenue broadly flat in 2025 vs 2024 with improving marginsGrocery, health food, onlineAcquired by Elixinol pre-2020; flagship to date—
Hemp Gold Protein (Hemp Foods Australia)Hemp protein powder; ranged in Costco in 2024; returning to Costco Australia and New Zealand in Q4 2026Club retail shoppers2024 Costco; relaunch Q4 2026—
Australian Primary Hemp — hemp seedsDe-hulled Australian-grown hemp seedRetail, bulkSince Nov 2017—
Australian Primary Hemp — Hemp Boost / Hemp BalanceMilled hemp powders (protein; protein-plus-fibre gut-health positioning)Health-conscious consumersPre-2019—
Australian Primary Hemp — cold-pressed hemp seed oilOmega-3, 6 and 9 oilRetail, bulkPre-2019—
Bulk hemp cultivation seed, hemp seed oil, protein powder, flourBulk ingredients and cultivation seed for growersFood manufacturers, growersOngoingContract
Hemp isolate / concentrate (with Australian Plant Proteins)Higher-protein, more soluble, lighter-flavour hemp protein designed to overcome the dark-green, ~50%-protein limitations of conventional hemp powder; allergen-friendly and non-GMO positioning; TSN to own IP with 15-year exclusivityFood and beverage formulators, exportStage One paid Dec 2022—
Ananda Food ingredients / Ananda EquineHemp ingredients for bulk, branded and private-label customers; equine products; cat litter (subject of earn-out)Bulk buyers, equine owners, pet ownersAcquired 2024—
Grocery hemp ingredient supplyFull supply contracts for two major grocery programs through 2027 (expanded from one full and one shared arrangement in 2025)Supermarket private-label programsContracts to 2027Contract

5B. Australia — Branded better-for-you grocery

Brand / productDescriptionStatus
Mt Elephant hemp seed and nut barsApricot & Nut, Honey & Nut, Salted Caramel; 100% Australian hemp; source of omega-3/6 and magnesiumLaunched Sep 2020; 7-Eleven (720 stores) from Nov 2020
Mt Elephant MylkOat-and-hemp milk, Original and Chocolate; vegan, low saturated fatColes (140 stores) and Woolworths (165 stores) 2021; Woolworths delisted Mar 2022
Mt Elephant almond and buckwheat pancakesVanilla and ChocolateColes from Jul 2021
Mt Elephant superfood protein ballsChocolate, Choc Cherry, HazelnutColes from Jul 2021
Mt Elephant baking productsBaking rangeWoolworths from Mar 2022; exited Woolworths end-2025
Mt Elephant (2026 repositioning)Brand repositioned in 2026 and now focused exclusively on Coles, with joint innovation on flavour, format and sustainabilityColes-only from 2026
Hemp and Honey Nut Bar; hemp and bush balm hand sanitiserLegacy APH SKUsLegacy

5C. Australia — Superfoods, wellness and pet

Brand / productDescriptionStatus
The Australian Superfood Co (The Super Food Co)Australian native foods, ingredients and beverages plus nutraceutical and cosmetic ingredients; grower and Indigenous-community supply relationships; export access to South Korea and the USAAcquired Jan 2022 (A$3 million); new opportunities progressing (FY25 release)
The Healthy Chef — protein powdersPremium protein and wellness powders, predominantly e-commerce; ~62% gross margin cited at acquisition (Oct 2024 investor presentation)Acquired late 2024; core growth brand
The Healthy Chef — Protein WaterFunctional beverage range; three new SKUs launched 2025Launched 2025
The Healthy Chef — menopause-focused productWomen's health productLaunched 2025
The Healthy Chef — limited-edition protein powdersTwo limited editions2,025
The Healthy Chef in PricelineStage-one rollout across ~410 Priceline pharmacies2,026
Field DayPet nutrition brand (TSN legacy)Product specifics not disclosed
Soul Seeds / Soul FoodsNutrition brand listed in EXL portfolio (May 2026 presentation; StockAnalysis profile)Details not disclosed

5D. Discontinued / divested

BrandDescriptionStatus
Elixinol (USA)Elixinol-branded hemp/CBD nutraceuticals and skincare; brand refresh and new products prepared in 2025, rollout planned Q1 2026Sold to Ananda Health, Inc., completed 4 Sep 2026; EXL retains brand rights outside the US
Duplicate hemp brandsRationalised in 2026Discontinued (Food & Drink Business, Sep 2026)

5E. Pending — Vitable

FeatureDetail
OfferingPersonalised daily supplement packs via subscription, driven by an online health assessment
Scale~7,851 active subscribers; ~1.84 million health assessments/quiz records
RevenueMore than A$5 million annual revenue (company statement)
Founded2019, by Larah Loutati and Ilyas Anane
Funding historyA$5.5 million Series A (2021) backed by Brenteca Investments; a 2023 round; 2024 media-for-equity round with ScaleUp Mediafund
StatusBinding agreement 24 Sep 2026; subject to EXL shareholder approval at a meeting expected early November 2026

Sources: Business News Australia; StartupResearcher; EXL announcement 24 Sep 2026.

Financial Narrative

Basis: EXL consolidated, fiscal years ending 31 December, AUD millions. Primary source: S&P Global Market Intelligence data via StockAnalysis.com (standardised), cross-checked against company Appendix 4E releases. Company-defined Adjusted EBITDA shown separately. Note that FY2021–FY2023 figures pre-date or only partly include the TSN merger (implemented August 2023), the Ananda Food acquisition (2024) and The Healthy Chef (late 2024).

6A. Income statement: notes and sources

Sources: StockAnalysis (S&P Global) income statement; EXL Appendix 4E FY21 (loss A$17.025 million, EPS -5.41c, Adjusted EBITDA -A$11.5 million); FY22 Appendix 4E (loss A$10.571 million, Adjusted EBITDA -A$8.538 million); FY24 Appendix 4E (loss A$1.722 million); FY25 Appendix 4E (loss A$5.5 million, EPS -2.15c vs -1.11c). FY24 Adjusted EBITDA was originally reported as a A$2.8 million loss (28 Feb 2025) and restated to A$3.0 million in the FY25 release — a discrepancy noted. FY24 net loss benefited from a one-off A$3.6 million tax benefit.

6B. Margins (%)

Revenue CAGR FY2021–FY2025 (derived): ~13.5% per year (A$9.34 million to A$15.50 million), almost entirely acquisition-driven. Organic growth in FY25 was low single digits at group level (+3.6%), with Australia +8% offset by the US decline.

Sources conflict on gross margin: the company reports 38% (FY24) and 39% (FY25), while S&P standardisation shows 35.8% and 36.9%, likely reflecting differing classification of freight or inventory costs. Both are shown.

6C. Balance sheet: notes and sources

Source: S&P Global via StockAnalysis (share counts as reported by S&P; which may be adjusted for capital reconstructions; the FY22 count of 39.5 million is inconsistent with the scheme's 1.1225-for-1 issue to 120.6 million TSN shares unless a consolidation occurred). Short- and long-term debt splits derived by analyst from S&P line items. At 30 June 2026: cash A$1.0 million, total debt A$4.03 million, net debt A$3.04 million, equity A$6.36 million, working capital -A$1.55 million. Net tangible assets swung from +A$0.3 million to -A$1.5 million during FY25 (-0.36 cents per share) (FY25 Appendix 4E).

6D. Cash flow: notes and sources

Source: S&P Global via StockAnalysis cash-flow statement; capex derived as OCF minus FCF. Note FY23 "cash acquisitions" of +0.19 reflects cash acquired with TSN. Company-reported net cash used in operating activities was A$3.2 million in FY25 vs A$3.5 million in FY24 (FY25 release).

6E. Ratios

All ratios derived by the analyst from the S&P data above. Net debt/EBITDA is not meaningful because EBITDA is negative in every year.

6F. Commentary on trends, inflections and drivers

Revenue. EXL's revenue troughed in FY2022 at A$7.06 million as the legacy Elixinol CBD business contracted (FY2021 revenue fell 38% and FY2022 a further 24%). Growth since then has been bought rather than built: the TSN merger (August 2023) lifted FY2023, and the Ananda Food and Healthy Chef acquisitions drove the 81% jump in FY2024. FY2025 growth of 3.6% masked divergent drivers — Australian e-commerce rose 163% to A$4.3 million on a full year of The Healthy Chef and six new products, while Australian retail fell 19% to A$7.1 million on supermarket SKU rationalisation, and US revenue fell from A$2.1 million to A$1.6 million on CBD branding restrictions (FY25 release).

Gross margin. The structural mix shift is the single most important positive trend. Lower-margin bulk ingredients fell from 24% to 14% of revenue, e-commerce rose from 21% to 38%, and quarterly gross margin climbed from ~37% (Q1 FY25) to 42% (Q4 FY25) and 45% (Q1 and Q2 FY26) (Q1 and Q2 FY26 4Cs). Management attributes 1H FY25 margin pressure to legacy contracts and unprofitable SKUs hit by global ingredient pricing.

Operating costs. Operating expenses rose 8% in FY25 because of one-off integration and streamlining costs, but the Q4 FY25 cost base was 30% below Q4 FY24, and 1H FY26 operating expenses fell A$1.1 million (25%) to A$3.3 million. Adjusted EBITDA turned positive in Q4 FY25.

Net loss. The FY24 net loss of A$1.7 million flatters underlying performance because of a one-off A$3.6 million tax benefit (recognition of deferred tax assets, now A$3.79 million on balance sheet). The FY25 loss of A$5.5 million is closer to the true run-rate of that year. The 1H FY26 loss narrowed, with the most recent half-year net loss approximately A$1.07 million versus A$2.41 million in the preceding half (Investing.com summary of semi-annual data).

Cash and balance sheet. Cash burn has fallen from A$14 million (FY21) to ~A$3.2 million (FY25), and underlying operating cash flow (excluding finance costs, tax and non-recurring items) was positive for three consecutive quarters to June 2026. However, statutory operating cash flow remained negative (net operating outflow A$0.58 million in Q2 FY26 and A$0.14 million in Q1 FY26), cash fell to ~A$1.0 million by June 2026, working capital is negative, and debt has roughly doubled to ~A$4 million (largely loan notes, partly secured over the former US business). The balance sheet is the binding constraint on strategy.

6G. Historical TSN/APH standalone financials: notes and sources

Sources: Stockhead (H1 FY21 revenue A$0.74 million, loss A$1.05 million vs A$4.85 million pcp — the H1 FY20 loss includes reverse-takeover costs); Food & Drink Business (H1 FY22 revenue A$1.6 million, EBITDA approximately -A$2.8 million); TSN H1 FY23 Appendix 4D/interim report.

Source: TSN H1 FY23 interim report (statements of financial position and changes in equity). TSN's half-year accounts carried a going-concern material uncertainty (H1 FY23 auditor's review report).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts

Australia

Hemp Foods Australia, Australian Primary Hemp, Mt Elephant, The Australian Superfood Co, Field Day, The Healthy Chef, Ananda Food / Ananda Equine, Soul Seeds/Soul Foods, contract manufacturing and bulk ingredients

Hemp seeds, oils, proteins; snack bars, pancakes, baking mixes; protein powders and protein waters; superfood ingredients; pet and equine products; bulk hemp

Americas (discontinued Sep 2026)

Elixinol LLC (Broomfield, Colorado)

Elixinol-branded hemp/CBD nutraceuticals and skincare

Rest of World

Elixinol BV, Elixinol Limited

Limited contribution; EXL retains the Elixinol brand outside the US

Revenue by Segment

SegmentFY2023FY2024FY2025

Australia revenue (AUD Mn)

—12.913.9

Americas / USA revenue (AUD Mn)

—2.11.6

Group revenue (AUD Mn)

8.2714.9615.50

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment Margins & Growth (%) and Revenue by Segment (%)

Segment metricFY2024FY2025

Australia YoY growth (%)

—8

Americas YoY growth (%, derived)

—-24

Australia share of group revenue (%, derived)

8690

Americas share of group revenue (%, derived)

1410

Brand / Period Metric Details

Brand / period metricValueSource

The Healthy Chef revenue, H1 FY25

1.7

H1 FY25 results (29 Aug 2025)

Hemp Foods Australia revenue, H1 FY25

2.4

H1 FY25 results

Elixinol USA revenue, H1 FY25

0.8

H1 FY25 results

Mt Elephant revenue, Q3 FY24 (quarter)

0.411 (+60% YoY)

Q3 FY24 4C (22 Oct 2024)

Hemp products revenue, 9 months to Sep 2026

6.4

Grafa (13 Oct 2026)

Continuing-operations revenue, H1 FY26

7.2 (+5.8%)

H1 FY26 Appendix 4D via Kalkine

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (AUD Mn)

9.347.068.2714.9615.50

Revenue growth (%)

-37.8-24.517.280.93.6

Cost of revenue (AUD Mn)

7.224.075.009.609.79

Gross profit (AUD Mn)

2.122.993.275.365.71

Operating expenses (AUD Mn)

20.0012.749.3110.4110.77

Operating income (AUD Mn)

-17.89-9.75-6.04-5.05-5.06

EBITDA, S&P basis (AUD Mn)

-17.40-9.57-5.92-4.51-4.41

Adjusted EBITDA, company basis (AUD Mn)

-11.50-8.54—-3.00-3.40

Interest expense (AUD Mn)

0.090.070.100.210.49

Net income attributable (AUD Mn)

-17.03-10.57-7.51-1.72-5.50

Basic EPS (AUD cents)

-5.41——-1.11-2.15

Diluted EPS (AUD cents)

-5.41——-1.11-2.15

Dividends per share (AUD cents)

00000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin, S&P basis (%)

22.742.339.535.836.9

Gross margin, company basis (%)

———3839

Operating margin (%)

-191.5-138.2-73.1-33.8-32.6

EBITDA margin, S&P basis (%)

-186.3-135.7-71.6-30.2-28.4

Net margin (%)

-182.3-149.8-90.8-11.5-35.5

Balance Sheet and Share Count (M)

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (AUD Mn)

25.3313.4911.7118.4515.96

Cash and equivalents (AUD Mn)

12.652.860.711.081.41

Inventory (AUD Mn)

2.201.743.663.892.66

Short-term debt incl. current leases (AUD Mn)

1.181.021.081.303.41

Long-term debt incl. leases (AUD Mn)

1.540.890.190.640.32

Total debt (AUD Mn)

2.721.901.261.943.73

Net debt (AUD Mn, negative = net cash)

-9.93-0.960.550.862.32

Total equity (AUD Mn)

19.089.166.4610.037.45

Goodwill and intangibles (AUD Mn)

0.460.152.306.185.15

Deferred tax assets (AUD Mn)

0003.593.79

Working capital (AUD Mn)

14.875.873.192.19-0.94

Shares outstanding (M)

39.4739.5279.09220.82413.99

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (AUD Mn)

-14.07-8.15-2.76-3.47-3.21

Capital expenditure (AUD Mn, derived)

0.160.010.010.060.07

Free cash flow (AUD Mn)

-14.23-8.16-2.77-3.53-3.28

Cash acquisitions (AUD Mn)

00-0.192.270.12

Financing cash flow (AUD Mn)

-1.16-0.761.613.923.65

Dividends paid (AUD Mn)

00000

Share buybacks (AUD Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE on year-end equity (%)

-89.3-115.4-116.3-17.1-73.8

ROA on year-end assets (%)

-67.2-78.4-64.1-9.3-34.5

ROIC proxy: EBIT / (equity + debt) (%)

-82.1-88.1-78.2-42.2-45.3

Current ratio (x)

4.152.711.641.440.86

Debt to equity (x)

0.140.210.200.190.50

Interest coverage: EBIT / interest (x)

-198.8-139.3-60.4-24.0-10.3

Asset turnover: revenue / year-end assets (x)

0.370.520.710.810.97

Inventory days (derived)

11115626714899

Receivable days (derived)

2537693225

Payable days (derived)

69971286957

Cash conversion cycle, days (derived)

679620811167

Cash Flow and Margin Analysis (%)

MetricH1 FY2020H1 FY2021H1 FY2022H1 FY2023

Revenue (AUD Mn)

—0.741.601.86

Revenue growth vs pcp (%)

—51.8103.615.9

Net loss after tax (AUD Mn)

-4.85-1.05-2.78-1.68

Basic EPS (AUD cents)

——-2.84-1.40

Operating cash flow (AUD Mn)

——-2.89-0.82

Employee benefits expense (AUD Mn)

——1.561.08

Marketing expense (AUD Mn)

——0.770.12

Balance Sheet

TSN balance sheet metric30 Jun 202130 Jun 202231 Dec 2022

Cash (AUD Mn)

4.100.380.51

Inventories (AUD Mn)

—3.263.28

Total assets (AUD Mn)

—7.437.11

Borrowings, current + non-current (AUD Mn)

—1.022.12

Total equity (AUD Mn)

5.314.903.36

Working capital (AUD Mn)

—2.901.52

Accumulated losses (AUD Mn)

-13.54-18.78-20.24

Revenue by Region

RegionFY2024FY2025

Australia revenue (AUD Mn)

12.913.9

USA revenue (AUD Mn)

2.11.6

Region growth

Region growthFY2025

Australia YoY growth (%)

8

USA YoY growth (%, derived)

-24

Revenue by Region by Australia Channel

Australia channelFY2024FY2025

E-commerce (AUD Mn)

1.64.3

Retail (AUD Mn)

8.87.1

Other incl. bulk / contract (AUD Mn, derived residual)

2.52.5

Share Price History

DatePrice (AUD)NoteSource

21 Apr 2026

0.008

+14.3% on Q1 FY26 update

Kalkine

31 Jul 2026

0.007

+16.7% intraday

StockAnalysis

13 Oct 2026

0.006

-14.3% on day

Kalkine

16 Oct 2026

0.007

Latest close

StockAnalysis

Valuation Multiples

MultipleEXLBasis

Market cap (AUD Mn)

~2.9

413.99 million shares × A$0.007

Enterprise value (AUD Mn, derived)

~5.9

Market cap + net debt A$3.04 million (Jun 2026)

EV / Sales, TTM (x, derived)

~0.37

TTM revenue A$15.9 million

P/B (x, derived)

~0.46

Equity A$6.36 million (Jun 2026)

Capital Markets

ItemStatus

Sell-side consensus

None identified; no price targets

Dividend history

No dividends paid or declared in FY2024 or FY2025, nor by TSN historically

Buyback authorisation

None (TSN confirmed no on-market buyback, Dec 2022)

Credit ratings (Moody's / S&P / Fitch)

Not rated

Debt maturity profile

~A$3.4 million of debt current at Dec 2025 (incl. current portion of long-term debt A$1.82 million and short-term debt A$1.44 million); loan notes rolled over in 2026; up to A$2 million convertible notes sought; A$500,000 Vitable-related convertible note.

Raise by Date

DateRaiseAmount (AUD Mn)

Jul–Dec 2021 (TSN)

Placement

4.70

Feb–Apr 2024

Capital raise for Ananda Food

3.16

Oct 2024

Placement + SPP for Healthy Chef

1.1 + up to 0.5

1H 2025

Debt and equity

1.5

2H 2025

Two-tranche raise

2.5

Sep 2026

Convertible note (Vitable-related)

0.5

Analyst Conclusions

22A. Management guidance

No formal numerical earnings guidance has been issued for FY26. Management priorities for 2H FY26 are sustaining the underlying operating cash-flow improvement and growing through new retail distribution (Priceline, Coles-focused Mt Elephant, Costco relaunch), product launches and additional B2B contracts. Post-Vitable, the company targets more than A$20 million annualised revenue at completion and ~A$27 million revenue with ~A$3 million EBITDA by 2028 on full earn-out realisation; an illustrative A$50 million revenue ambition over three to five years is explicitly not guidance.

22B. Consensus

No broker consensus exists. TTM revenue to June 2026 was A$15.9 million (+6.1% YoY, StockAnalysis).

22C. Bull case

  1. Margin-led turnaround is real: gross margin up eight points year-on-year to 45%, opex down 25%, and three straight quarters of positive underlying operating cash flow suggest the business can self-fund at current scale.

  2. Vitable is cheap, structured, aligned: A$2.5 million headline scrip for more than A$5 million of recurring revenue (~0.5x sales) with most upside consideration contingent on market-cap and performance hurdles; cross-sell into a high-margin Healthy Chef range could lift group margins further.

  3. Option value at a tiny valuation: at ~0.37x EV/sales, the market prices in failure; delivery of the 2028 targets (~A$3 million EBITDA) would imply a multiple of today's ~A$6 million enterprise value.

22D. Bear case

  1. Balance sheet is too thin: ~A$1.0 million cash, ~A$4 million debt and negative working capital leave little margin for error; any trading setback forces another sub-cent raise.

  2. Dilution overwhelms value creation: up to 666.7 million deferred Vitable shares on a 414 million base, plus convertible notes, mean per-share value may lag business improvement even if the strategy works.

  3. Track record of misses: the FY25 EBITDA break-even target was missed, both legacy companies (Elixinol Global and TSN) lost cumulatively large sums, and branded grocery positions (Mt Elephant) have repeatedly been delisted.

22E. Key catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timing
Notice of General Meeting and EGM vote on Vitable; ASX waiver outcomeOct–Nov 2026 (approval date 27 Nov 2026)
Vitable completion; issue of deferred consideration sharesProposed 7 Dec 2026
Q3 FY26 4C (quarter to Sep 2026)Late Oct 2026
Hemp Gold Protein Costco relaunchQ4 2026
FY26 full-year results (first Australia-only year)Late Feb 2027
Statutory (not just "underlying") operating cash-flow break-evenEach quarterly 4C
Convertible note terms and loan-note maturitiesOngoing
Priceline stage-two rollout and Mt Elephant Coles innovation2,027
Further M&A announcementsOngoing

22F. Analyst verdict

The Sustainable Nutrition Group no longer exists as an investable security. Its listed history — a failed biotech shell reborn as Australian Primary Hemp in 2019, renamed in 2021 and absorbed by Elixinol Wellness for scrip worth about three cents a share in 2023 — destroyed most of the capital raised along the way. Exposure to the APH, Mt Elephant, Superfood Co and Field Day businesses today is available only through Elixinol Wellness (ASX: EXL).

EXL itself is a classic micro-cap turnaround with genuine but early evidence of operational progress. The improvements are not cosmetic: gross margin has risen from the mid-30s to 45%, the cost base has been cut by roughly a quarter to a third, unprofitable US operations have been sold, and underlying operating cash flow has been positive for three consecutive quarters. Management has also concentrated resources on its one clearly advantaged asset, The Healthy Chef, and secured hemp ingredient volume through 2027.

The problem is the capital structure. With roughly A$1 million of cash, around A$4 million of debt, negative working capital and negative tangible equity, the company has almost no buffer, and its growth strategy depends on paying for acquisitions in shares priced below one cent. The Vitable transaction is strategically coherent and attractively structured on an enterprise basis, but the potential issue of up to 666.7 million deferred shares illustrates how readily per-share value can be diluted even when the business improves.

On balance, EXL should be regarded as a high-risk, speculative position. The equity offers asymmetric upside if statutory cash-flow break-even is reached and Vitable delivers its earn-out targets, but the base case is continued dilution. Key evidence to watch is whether statutory — not merely underlying — operating cash flow turns positive in the first half of 2027.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior roles / background

Gavin Evans

Independent Non-Executive Chair

Since Dec 2025

Founder of OpenWay Food Co., a vertically integrated portfolio of better-for-you brands (Red Tractor, Table of Plenty, Keep It Cleaner); board roles across FMCG, resources, fintech and not-for-profit; M&A experience

Natalie Butler

CEO & Executive Director

—

Commercial and operational experience in consumer health (per Chair)

Adam Dimitropoulos

Chief Financial Officer

——

Katie Mackenzie

Investor Relations

Current

—

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext
2024

Ron Dufficy serving as CEO & MD; David Fenton as Chair

Led Ananda Food and Healthy Chef acquisitions

2025

Leadership team rebuilt: Natalie Butler (CEO & ED), Adam Dimitropoulos (CFO)

Post-integration reset

Dec 2025

Gavin Evans appointed Chair

Described by Evans as a pivotal moment for the company

Earlier (Elixinol Global era)

Founder Paul Benhaim as Chair; CEO changes including Stratos Karousos and Oliver Horn (ex-Swisse)

Elixinol Global's CBD-focused era (Hemp Industry Daily)

Board of Directors

NameRole

Pauline Gately

Non-Executive Chair and Interim Executive Chair

James Hood

Non-Executive Director

Shane Gild

Independent Non-Executive Director

Thomas Siebel

Independent Non-Executive Director

Melanie Leydin

Company Secretary

Neale Joseph

Former MD & CEO (resigned mid-2022)

Karun Moses

COO (stepped up after CEO departure)

Cameron Petricevic

Only Alchemia director retained post-RTO (2019)

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeRelative positioning

Hemp foods / ingredients

Ecofibre Ltd (ASX: EOF) — formerly owned Ananda Food; owns Ananda Health (US)

Listed

Larger diversified group (FY24 revenue ~A$28.0 million) but heavily loss-making; exited Australian hemp food by selling to EXL

Hemp foods

Essential Hemp, Hemp Farms Australia and other independent domestic processors

Private

Fragmented smaller rivals; EXL claims a leading Australian hemp-foods supply position

Hemp foods

Imported hemp seed products (e.g., Canadian suppliers)

Private/foreign

Price competition; APH's founding thesis was displacing imports

Plant-based milks

Noumi Ltd (ASX: NOU) — MILKLAB, Australia's Own

Listed

FY26 revenue A$648.4 million; plant-based milk revenue A$186.3 million; far larger scale

Plant-based milks

Sanitarium (So Good), Vitasoy, Oatly

Private / foreign listed

Dominant brands that crowded out Mt Elephant Mylk

Protein / wellness powders

Musashi, Macro Mike, Nutra Organics, Bulk Nutrients, private-label

Private

Compete with The Healthy Chef in e-commerce and pharmacy

Vitamins and supplements

Swisse (H&H Group), Blackmores (Kirin), Nature's Way, Life-Space (Asahi)

Multinational subsidiaries

Dominant in pharmacy; context for Vitable

Personalised supplements / DTC health

Eucalyptus (being acquired by Hims & Hers), Persona Nutrition (Nestlé), Thorne (P&G)

Global

Validate category; vastly better capitalised

Better-for-you snacks

Carman's, Table of Plenty (OpenWay), Blue Dinosaur, supermarket private label

Private

Compete with Mt Elephant for shrinking grocery shelf space

Superfood ingredients

Bulk ingredient traders and importers

Private

Commodity pricing pressure

Peer Comparison FY2025

MetricEXL (FY Dec 2025)Noumi (FY Jun 2026)Ecofibre (FY Jun 2024)

Revenue (AUD Mn)

15.5648.428.0

Revenue growth (%)

3.68.8-13.9

Gross margin (%)

39——

Adjusted EBITDA (AUD Mn)

-3.461.8—

Net profit after tax (AUD Mn)

-5.5-67.2-39.2

Company Snapshot

$10M

Revenue

$2M

Market Cap

2017

Founded

Melbourne, Australia

Headquarters

SWOT Analysis

Strengths

  • Gross margin expansion: quarterly GM rose from ~37% (Q1 FY25) to 45% (Q1 and Q2 FY26) (Q1/Q2 FY26 4Cs).
  • High-margin brand: The Healthy Chef carried ~62% gross margin at acquisition (Oct 2024 presentation) and drove a 163% rise in Australian e-commerce revenue to A$4.3 million in FY25.
  • Secured hemp volume: full supply contracts for two major grocery programs through 2027 (Grafa, Oct 2026).
  • Lean cost base: 1H FY26 operating expenses down 25% to A$3.3 million; Q4 FY25 cost base 30% below pcp.
  • Cash-flow inflection: three consecutive quarters of positive underlying operating cash flow to June 2026.
  • Record trading: Q2 FY26 revenue of A$4.3 million was the highest quarterly figure reported (Q2 FY26 4C).
  • Integrated supply chain: APH's grower network and processing heritage, combined with Ananda Food assets, gives provenance credentials.

Weaknesses

  • Persistent losses: net losses every year FY2021–FY2025, totalling ~A$42 million (S&P data).
  • Thin liquidity: cash of A$0.996 million at 30 June 2026 against total debt of ~A$4.0 million.
  • Negative working capital and NTA: working capital -A$1.55 million (Jun 2026); NTA -A$1.5 million (Dec 2025).
  • Sub-scale: FY25 revenue of A$15.5 million is ~2% of Noumi's.
  • Brand attrition: Mt Elephant lost Woolworths ranging at end-2025 after losing Mylk ranging in 2022.
  • Guidance credibility: FY25 EBITDA break-even target (Feb 2025) was missed on a full-year basis (Adjusted EBITDA loss A$3.4 million).
  • Serial dilution: share count rose from ~39.5 million (FY22, S&P) to ~414 million (FY25).

Opportunities

  • Vitable: more than A$5 million of recurring subscription revenue, taking group revenue above A$20 million; target ~A$27 million revenue and ~A$3 million EBITDA by 2028.
  • Cross-selling: Healthy Chef products into Vitable's subscriber base and vice versa.
  • Pharmacy rollout: ~410 Priceline stores for The Healthy Chef.
  • Costco relaunch: Hemp Gold Protein returning to Costco AU/NZ in Q4 2026.
  • Roll-up M&A: Chair's track record building OpenWay Food Co. and stated pipeline focus.
  • Hemp isolate IP: TSN-owned isolate with 15-year exclusivity could support premium ingredient sales if commercialised.

Threats

  • Retailer power: supermarket rationalisation already reduced Australian retail revenue by 19% in FY25.
  • Funding risk: further capital needs at sub-cent share prices imply heavy dilution.
  • Dilution from Vitable: up to 666.7 million deferred consideration shares — more than the 414 million currently on issue.
  • Ingredient price volatility: global ingredient pricing pressured 1H FY25 margins.
  • Harvest risk: weather-related harvest failures (evidenced at Ananda Food under Ecofibre in FY23).
  • Competition from scaled players: global strategics (P&G, Nestlé, Hims & Hers) are investing heavily in personalised supplements.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1H 2025A$1.5 million debt and equity raise completedLiquidity bridge
2025New CEO (Natalie Butler) and CFO (Adam Dimitropoulos) installedLeadership reset
2025Two key customers discontinue SKUs containing superfood ingredients; some hemp contracts reducedRevenue headwind (later reversed)
29 Aug 2025H1 FY25 results: revenue +12.8% to A$7.6 million; GM 37%; Adjusted EBITDA loss A$2.2 million; operating outflow A$1.4 million; cash A$1.1 millionGrowth with continued losses
2H 2025Two-tranche A$2.5 million capital raiseBalance-sheet support
Q4 2025Adjusted EBITDA positive; underlying operating cash flow positive; GM 42%; cost base -30% YoYInflection quarter
Dec 2025Gavin Evans appointed ChairGovernance refresh, M&A experience
End-2025Mt Elephant exits WoolworthsShort-term revenue loss; Coles focus
11–12 Feb 2026Q4 FY25 results webinarDisclosed channel mix shift
27 Feb 2026FY25 results: revenue A$15.5 million (+3.6%); net loss A$5.5 million; NTA turns negativeWeakened balance sheet
21 Apr 2026Q1 FY26 4C: GM 45% (+8 pts); second positive underlying cash quarter; operating outflow A$0.14 million; shares +14% to A$0.008Margin momentum
19 May 2026Business update: loan-note holders roll over; new shareholders; seeking approval for up to A$2 million convertible notesRefinancing
27 May 2026AGM; Chair's address on stabilisation and "everyday wellness" focusStrategy communication
28 Jul 2026Q2 FY26 4C: record quarterly revenue A$4.3 million (+5%); GM 45%; third positive underlying cash quarter; operating outflow A$0.58 million; cash A$1.0 millionRecord sales, thin cash
31 Aug 2026H1 FY26 Appendix 4D: continuing revenue A$7.2 million (+5.8%); opex -25% to A$3.3 million; binding US sale agreement announcedNarrowed loss
4 Sep 2026US business sale to Ananda Health completed (~A$465,000)Strategic simplification
7 Sep 2026Completion announcement—
24 Sep 2026Binding agreement to acquire Vitable; A$500,000 convertible noteTransformational M&A
Late Sep 2026Appendix 3B: up to 666.7 million deferred consideration shares at A$0.00525, issue proposed 7 Dec 2026, approval by 27 Nov 2026Large potential dilution
13 Oct 2026Nine-month hemp sales A$6.4 million; full supply contracts for two grocery programs to 2027; Hemp Gold Protein back to Costco AU/NZ in Q4 2026Hemp business recovering
Early Oct 2026Notice of General Meeting for Vitable expectedCatalyst
13 Oct 2026Share price A$0.006 (-14.3% on day)Volatility

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Revenue rose from AUD 9.3 Mn in FY2021 to AUD 15.5 Mn in FY2025.
The Sustainable Nutrition Group Ltd — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue9.37.18.31515.5
Cost of revenue7.24.159.69.8
Gross profit2.133.35.45.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Delisted.com.au — The Sustainable Nutrition Group Ltd (ASX: TSN) delisting record (delisted.com.au)
  2. The Mayne Report — trading history note on APH/TSN (maynereport.com)
  3. TSN Appendix 4D and Interim Report, half-year ended 31 Dec 2022 (ASX, 28 Feb 2023) (announcements.asx.com.au)
  4. Food & Drink Business — TSN extended trading halt (foodanddrinkbusiness.com.au)
  5. Stockhead — Alchemia RTO of APH (stockhead.com.au)
  6. SmallCaps — Alchemia completes shift to APH (smallcaps.com.au)
  7. AusFoodNews — APH capital raise and founding story (Sep 2019) (ausfoodnews.com.au)
  8. InvestSMART — APH announcement log (Oct 2019 reinstatement) (investsmart.com.au)
  9. Market Index — APH profile and holders (marketindex.com.au)
  10. Stockhead — APH Coles Mylk deal (stockhead.com.au)
  11. Australian Manufacturing — second Coles agreement (australianmanufacturing.com.au)
  12. Food & Drink Business — Mt Elephant 7-Eleven deal (foodanddrinkbusiness.com.au)
  13. Stockhead — TSN MD interview, APP partnership (stockhead.com.au)
  14. FoodBev — TSN acquires The Australian Superfood Company (archive.foodbev.com)
  15. MarketBeat — TSN profile (marketbeat.com)
  16. iocharts — TSN.AU (delisted) data (preview.iocharts.io)
  17. EXL FY25 results release (27 Feb 2026) (bulletin.webull.com)
  18. EXL Q4 FY25 results and outlook presentation (12 Feb 2026) (bulletin.webull.com)
  19. Q4 FY25 earnings call transcript (Seeking Alpha / ROIC.ai) · roic.ai
  20. The Globe and Mail / TipRanks — EXL FY25 Appendix 4E summary (theglobeandmail.com)
  21. StockAnalysis — EXL income statement, balance sheet, cash flow, overview · stockanalysis.com · stockanalysis.com · stockanalysis.com
  22. StockAnalysis — EXL revenue history (stockanalysis.com)
  23. Investing.com — EXL financial summary (investing.com)
  24. multiples.vc — EXL valuation multiples (multiples.vc)
  25. EXL FY21 Appendix 4E (asx.com.au)
  26. EXL FY22 Appendix 4E (announcements.asx.com.au)
  27. EXL FY24 Appendix 4E and results release · announcements.asx.com.au
  28. EXL H1 FY25 results (29 Aug 2025) (announcements.asx.com.au)
  29. EXL Q3 FY24 4C (22 Oct 2024) (announcements.asx.com.au)
  30. EXL Healthy Chef acquisition presentation (3 Oct 2024) (announcements.asx.com.au)
  31. Food & Drink Business — EXL acquires The Healthy Chef (foodanddrinkbusiness.com.au)
  32. Food & Drink Business — EXL to acquire Ananda Food; EGM · foodanddrinkbusiness.com.au
  33. EXL Q1 FY26 4C (21 Apr 2026) (bulletin.webull.com)
  34. EXL business update presentation (19 May 2026) (bulletin.webull.com)
  35. EXL AGM Chair's address (27 May 2026) (bulletin.webull.com)
  36. EXL Q2 FY26 4C (28 Jul 2026) (bulletin.webull.com)
  37. Kalkine — EXL record Q2 revenue; Q1 share move; US divestment; Vitable coverage; Appendix 3B · kalkine.com.au · kalkine.com.au · kalkine.com.au · kalkine.com.au · kalkine.com.au
  38. EXL completion of US divestment (7 Sep 2026) (announcements.asx.com.au)
  39. Food & Drink Business — EXL exits US as losses narrow (foodanddrinkbusiness.com.au)
  40. EXL Vitable announcement (24 Sep 2026) (announcements.asx.com.au)
  41. Business News Australia — Vitable deal (businessnewsaustralia.com)
  42. SmallCaps — Vitable deal (smallcaps.com.au)
  43. NutraIngredients — Vitable deal (nutraingredients.com)
  44. StartupResearcher — Vitable term sheet (startupresearcher.com)
  45. Grafa — EXL nine-month hemp sales (grafa.com)
  46. LinkedIn (Felipe Favaro) — EXL/TSN scheme distribution reach (au.linkedin.com)
  47. Hemp Industry Daily — Elixinol Global CEO changes (hempindustrydaily.com)
  48. CB Insights — Elixinol (US) profile (cbinsights.com)
  49. Noumi FY26 results (20 Aug 2026) (bulletin.webull.com)
  50. Stockwirex — Noumi FY26 summary and Arrovest scheme (stockwirex.com)
  51. Ecofibre FY24 Appendix 4E (announcements.asx.com.au)
  52. TipRanks — Ecofibre revenue history (tipranks.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.